Financials Dr. Hönle AG

Equities

Market Closed - Xetra Other stock markets 11:36:20 2024-04-26 am EDT			5-day change	1st Jan Change
19.9 ^EUR	0.00%		-0.50%	+13.71%

Feb. 26	Dr. Hönle AG Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
Jan. 25	Dr. Hönle AG Reports Earnings Results for the Full Year Ended September 30, 2023	CI

Fiscal Period: September	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	275.6	303.2	245.5	88.02	107.6	120.6	-	-
Enterprise Value (EV) ¹	277.2	315.3	287	140.3	155.1	160.1	158.7	120.6
P/E ratio	22.1 x	53.9 x	-50.6 x	-6.6 x	-9.75 x	41.5 x	14.3 x	-
Yield	1.6%	0.91%	0.49%	-	-	0.75%	1.51%	-
Capitalization / Revenue	2.56 x	3.23 x	2.13 x	0.7 x	1.01 x	1.1 x	0.97 x	0.92 x
EV / Revenue	2.57 x	3.36 x	2.49 x	1.11 x	1.46 x	1.47 x	1.27 x	0.92 x
EV / EBITDA	13.6 x	21.4 x	20.7 x	32.3 x	477 x	12.7 x	7.65 x	-
EV / FCF	-118 x	-13.7 x	-12.3 x	-12 x	742 x	20 x	37.8 x	-
FCF Yield	-0.85%	-7.28%	-8.14%	-8.35%	0.13%	5%	2.65%	-
Price to Book	3.06 x	-	2.22 x	0.82 x	1.12 x	1.22 x	1.14 x	-
Nbr of stocks (in thousands)	5,512	5,512	6,062	6,062	6,062	6,062	-	-
Reference price ²	50.00	55.00	40.50	14.52	17.75	19.90	19.90	19.90
Announcement Date	1/28/20	1/28/21	1/27/22	1/30/23	2/1/24	-	-	-

¹EUR in Million²EUR

Estimates

Fiscal Period: Settembre	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	107.7	93.88	115.2	126.5	106.3	109.3	124.9	131.3
EBITDA ¹	20.32	14.71	13.85	4.349	0.325	12.6	20.75	-
EBIT ¹	17	8.099	7.871	-10.12	-9.418	6	13.3	17.2
Operating Margin	15.78%	8.63%	6.83%	-8%	-8.86%	5.49%	10.65%	13.1%
Earnings before Tax (EBT) ¹	16.87	7.846	-0.608	-11.55	-10.98	4.4	12	-
Net income ¹	12.48	5.678	-4.82	-13.36	-11.01	2.9	8.45	-
Net margin	11.58%	6.05%	-4.19%	-10.56%	-10.35%	2.65%	6.77%	-
EPS ²	2.260	1.020	-0.8000	-2.200	-1.820	0.4800	1.390	-
Free Cash Flow ¹	-2.354	-22.96	-23.37	-11.72	0.209	8	4.2	-
FCF margin	-2.18%	-24.46%	-20.29%	-9.26%	0.2%	7.32%	3.36%	-
FCF Conversion (EBITDA)	-	-	-	-	64.31%	63.49%	20.24%	-
FCF Conversion (Net income)	-	-	-	-	-	275.86%	49.7%	-
Dividend per Share ²	0.8000	0.5000	0.2000	-	-	0.1500	0.3000	-
Announcement Date	1/28/20	1/28/21	1/27/22	1/30/23	2/1/24	-	-	-

¹EUR in Million²EUR

Estimates

Fiscal Period: September	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	1.65	12.1	41.5	52.3	47.5	39.5	38.1	-
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	0.0811 x	0.8244 x	2.994 x	12.03 x	146.1 x	3.135 x	1.836 x	-
Free Cash Flow ¹	-2.35	-23	-23.4	-11.7	0.21	8	4.2	-
ROE (net income / shareholders' equity)	14.1%	5.5%	-4.25%	-12.3%	-10.9%	3%	7.6%	-
ROA (Net income/ Total Assets)	-	-	-	-	-	-	-	-
Assets ¹	-	-	-	-	-	-	-	-
Book Value Per Share ²	16.30	-	18.30	17.60	15.80	16.30	17.40	-
Cash Flow per Share	-	-	-	-	-	-	-	-
Capex ¹	19.3	30.2	17.1	4.31	2.93	5	6.3	-
Capex / Sales	17.89%	32.17%	14.84%	3.41%	2.76%	4.57%	5.04%	-
Announcement Date	1/28/20	1/28/21	1/27/22	1/30/23	2/1/24	-	-	-

¹EUR in Million²EUR

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

C-

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

19.9 EUR

Average target price

29.15 EUR

Spread / Average Target

+46.48%

	1st Jan change	Capi.
DR. HÖNLE AG	+13.71%	129M
ATLAS COPCO AB	+11.73%	82.35B
PARKER-HANNIFIN CORPORATION	+20.17%	71.09B
INGERSOLL RAND INC.	+20.89%	37.73B
XYLEM INC.	+15.77%	32.01B
FANUC CORPORATION	+9.19%	27.2B
FORTIVE CORPORATION	+3.18%	26.74B
SANDVIK AB	+4.22%	26B
TECHTRONIC INDUSTRIES CO. LTD.	+16.93%	25.5B
DOVER CORPORATION	+17.14%	24.76B